【摘要】：第一部分Notch-1基因在吉西他濱誘導(dǎo)人胰腺癌細(xì)胞上皮-間質(zhì)轉(zhuǎn)化中的表達(dá)及作用機(jī)制研究目的：探討Notch-1在吉西他濱(GEM)誘導(dǎo)的人胰腺癌Panc-1細(xì)胞上皮間葉樣表型轉(zhuǎn)化(EMT)中的表達(dá)及作用機(jī)制。方法：低劑量、較長(zhǎng)時(shí)間GEM處理胰腺癌Panc-1細(xì)胞,觀察細(xì)胞形態(tài)學(xué)改變,Western Blot和RT-PCR法檢測(cè)EMT標(biāo)志物、Notch-1及相關(guān)轉(zhuǎn)錄因子的表達(dá),免疫熒光技術(shù)檢測(cè)E-cadherin及vimentin的表達(dá),Transwell小室檢測(cè)EMT細(xì)胞的遷移和侵襲能力。結(jié)果：GEM誘導(dǎo)胰腺癌Panc-1細(xì)胞的EMT最適藥物濃度為5-10mM,最適時(shí)間為9天；EMT標(biāo)志物E-cadherin表達(dá)下調(diào),vimentin表達(dá)上調(diào),Notch-1和相關(guān)轉(zhuǎn)錄因子的表達(dá)上調(diào)。EMT細(xì)胞遷移和侵襲能力明顯增強(qiáng)。結(jié)論：適當(dāng)濃度的GEM持續(xù)作用于人胰腺癌Panc-1細(xì)胞,可誘導(dǎo)Panc-1細(xì)胞EMT, Notch-1是該過(guò)程的重要信號(hào)通路,且胰腺癌細(xì)胞發(fā)生EMT改變后遷移和侵襲能力明顯增強(qiáng)。第二部分側(cè)群細(xì)胞及ABC轉(zhuǎn)運(yùn)體家族在吉西他濱誘導(dǎo)人胰腺癌細(xì)胞上皮-間質(zhì)轉(zhuǎn)化中的作用機(jī)制研究目的：探討側(cè)群細(xì)胞(SP)及ABCG2在吉西他濱誘導(dǎo)人胰腺癌細(xì)胞EMT中的作用機(jī)制研究。方法：低劑量、較長(zhǎng)時(shí)間GEM處理胰腺癌Panc-1細(xì)胞,Western Blot和RT-PCR法檢測(cè)EMT改變的Panc-1細(xì)胞中ABC轉(zhuǎn)運(yùn)體家族ABCB1、ABCC1及ABCG2的表達(dá)。熒光激活細(xì)胞分選法(FACS)分離SP細(xì)胞,對(duì)比EMT改變前后SP細(xì)胞的含量變化。結(jié)果：胰腺癌Panc-1細(xì)胞EMT后ABC轉(zhuǎn)運(yùn)體家族ABCB1、ABCC1、ABCG2表達(dá)明顯上調(diào),且發(fā)生EMT改變后SP細(xì)胞含量顯著增加(P0.05)。結(jié)論：人胰腺癌細(xì)胞EMT可使腫瘤CSC相關(guān)蛋白表達(dá)上調(diào),同時(shí)可增加胰腺癌CSC的含量,有助于胰腺癌細(xì)胞的增殖、侵襲及耐藥。第三部分Notch-1 siRNA在人胰腺癌細(xì)胞問(wèn)質(zhì)-上皮轉(zhuǎn)化中的作用及側(cè)群細(xì)胞、ABC轉(zhuǎn)運(yùn)體家族的表達(dá)機(jī)制研究目的：探討Notch-1 siRNA對(duì)人胰腺癌細(xì)胞間質(zhì)-上皮轉(zhuǎn)化(MET)的作用,以及SP細(xì)胞和ABCG2的表達(dá)機(jī)制研究。方法：Notch-1 siRNA轉(zhuǎn)染EMT改變的人胰腺癌Panc-1細(xì)胞,Western Blot和RT-PCR法檢測(cè)EMT標(biāo)志物E-cadherin、vimentin及相關(guān)轉(zhuǎn)錄因子的表達(dá),同時(shí)檢測(cè)ABC轉(zhuǎn)運(yùn)體家族成員的表達(dá),FACS檢測(cè)SP細(xì)胞的改變,Transwell小室檢測(cè)MET細(xì)胞遷移和侵襲能力的改變。結(jié)果：Notch-1 siRNA可使EMT改變的Panc-1細(xì)胞發(fā)生MET, EMT標(biāo)志物E-cadherin表達(dá)上調(diào),vimentin及相關(guān)轉(zhuǎn)錄因子表達(dá)下調(diào),MET細(xì)胞遷移和侵襲能力下降,同時(shí),ABC轉(zhuǎn)運(yùn)體家族成員表達(dá)下調(diào),SP細(xì)胞含量明顯減少。結(jié)論：Notch-1 siRNA可抑制Notch-1信號(hào)通路,Notch-1是Panc-1細(xì)胞EMT的重要信號(hào)通路；EMT可促進(jìn)Panc-1細(xì)胞侵襲、轉(zhuǎn)移及CSC特性的表達(dá),抑制Notch-1信號(hào)通路可阻止胰腺癌細(xì)胞EMT,從而抑制其侵襲、轉(zhuǎn)移及耐藥等特性。
[Abstract]:Part I expression of Notch-1 gene in gemcitabine-induced epithelial-interstitial transformation of human pancreatic cancer cells objective: to investigate the role of Notch-1 in Panc-1 cells induced by gemcitabine (GEM) Expression and mechanism of mesenchymal phenotypic transformation in (EMT). Methods: Panc-1 cells of pancreatic cancer were treated with GEM at low dose for a long time. The expression of EMT markers, Notch-1 and related transcription factors were detected by, Western Blot and RT-PCR. The expression of E-cadherin and vimentin was detected by immunofluorescence technique, and the migration and invasion of EMT cells were detected by Transwell chamber. Results: the optimal concentration of EMT in Panc-1 cells induced by GEM was 5-10 mm and the optimal time was 9 days. The expression of EMT marker E-cadherin was down-regulated, the expression of vimentin was up-regulated, and the expression of Notch-1 and related transcription factors was up-regulated. The migration and invasion ability of EMT cells was obviously enhanced. Conclusion: the sustained action of GEM at appropriate concentration on human pancreatic cancer Panc-1 cells can induce EMT, Notch-1 of Panc-1 cells to be an important signal pathway in this process, and the migration and invasion ability of pancreatic cancer cells after EMT changes is obviously enhanced. The role of ABC transporter family in the epithelial-interstitial transformation of human pancreatic cancer cells induced by gemcitabine objective: to investigate the role of (SP) and ABCG2 in gemcitabine-induced human pancreatic cancer cells Study on the mechanism of action in EMT. Methods:, Western Blot and RT-PCR were used to detect the expression of ABC transporter family ABCB1,ABCC1 and ABCG2 in Panc-1 cells treated with low dose GEM for a long time. SP cells were isolated by fluorescence activated cell sorting (FACS), and the changes of SP cell content before and after EMT were compared. Results: the expression of ABCB1,ABCC1,ABCG2 of ABC transporter family was up-regulated in Panc-1 cells of pancreatic cancer after EMT, and the content of SP cells increased significantly after EMT change (P0.05). Conclusion: human pancreatic cancer cell line EMT can up-regulate the expression of CSC related protein and increase the content of CSC in pancreatic carcinoma, which is helpful to the proliferation, invasion and drug resistance of pancreatic cancer cells. The role of Notch-1 siRNA in the Transformation of Human Pancreatic Cancer cells into Interstitial epithelium and the expression Mechanism of ABC Transporter Family in Human Pancreatic Cancer cells objective: to investigate the effect of Notch-1 siRNA on the transformation of (MET) into interstitial epithelium of human pancreatic cancer cells. And the expression mechanism of SP cells and ABCG2. Methods: the expression of EMT marker E-cadherin vimentin and related transcription factors was detected by, Western Blot and RT-PCR in Panc-1 cells transfected with EMT by Notch-1 siRNA, and the expression of ABC transporter family members was also detected. FACS was used to detect the change of SP cells, and Transwell chamber was used to detect the changes of migration and invasion ability of MET cells. Results: Notch-1 siRNA up-regulated the expression of MET, EMT marker E-cadherin, down-regulated the expression of vimentin and related transcription factors, decreased the migration and invasion of MET cells, and down-regulated the expression of ABC transporter family members. The content of SP cells decreased significantly. Conclusion: Notch-1 siRNA can inhibit Notch-1 signaling pathway and Notch-1 is an important signal pathway of EMT in Panc-1 cells. EMT can promote the invasion, metastasis and expression of CSC in Panc-1 cells. Inhibiting Notch-1 signaling pathway can inhibit the invasion, metastasis and drug resistance of pancreatic cancer cell EMT,.
【學(xué)位授予單位】：武漢大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2016
【分類號(hào)】：R735.9

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張麗;夏德雨;李國(guó)輝;蔣姍姍;谷芳娜;梁英民;;Notch信號(hào)在急性早幼粒細(xì)胞白血病患者骨髓中的表達(dá)[J];第四軍醫(yī)大學(xué)學(xué)報(bào);2009年24期

2 姜萌;何奔;;Notch信號(hào)對(duì)血管新生調(diào)控作用的研究進(jìn)展[J];上海交通大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年05期

3 ;Effect of Trastuzumab on Notch-1 Signaling Pathway in Breast Cancer SK-BR3 Cells[J];Chinese Journal of Cancer Research;2012年03期

4 魯茁壯,王立生,吳祖澤;Notch信號(hào)通路研究進(jìn)展[J];生理科學(xué)進(jìn)展;2004年02期

5 張謙慎;Notch信號(hào)與肺發(fā)育[J];中國(guó)當(dāng)代兒科雜志;2004年02期

6 孫力,詹啟敏,章文華;Notch信號(hào)通路與腫瘤[J];國(guó)外醫(yī)學(xué)(腫瘤學(xué)分冊(cè));2004年09期

7 張謙慎,常立文,劉漢楚,容志惠,祝華平,陳紅兵,李文斌;Notch信號(hào)與大鼠肺發(fā)育的關(guān)系研究[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2004年03期

8 張謙慎,常立文,劉漢楚,容志惠,陳紅兵;TEMPORAL EXPRESSION OF NOTCH RECEPTORS DURING LUNG DEVELOPMENT IN RAT[J];Journal of Shanghai Second Medical University;2005年02期

9 吳穎亞;王季石;;Notch及其配體在血液系統(tǒng)中的作用[J];國(guó)外醫(yī)學(xué).輸血及血液學(xué)分冊(cè);2005年05期

10 張謙慎,常立文,劉漢楚,容志惠,陳紅兵;Relationship between Notch Receptors and Hyperoxia-induced Lung Injury in Newborn Rats[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)英德文版);2005年02期

相關(guān)會(huì)議論文 前10條

1 張麗;梁英民;夏德雨;李國(guó)輝;蔣姍姍;谷芳娜;;Notch信號(hào)在急性早幼粒細(xì)胞白血病患者骨髓中的表達(dá)研究[A];第12屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要[C];2009年

2 ;Expression profile of Notch-related genes in multi-drug resistant K562/A02 cells compared with parental K562 cells[A];第12屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要[C];2009年

3 ;Notch signaling in lymphopoiesis[A];第10屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要匯編[C];2005年

4 韓驊;;Notch信號(hào)途徑的功能和作用機(jī)理的研究[A];全面建設(shè)小康社會(huì)：中國(guó)科技工作者的歷史責(zé)任——中國(guó)科協(xié)2003年學(xué)術(shù)年會(huì)論文集（下）[C];2003年

5 趙昱;侯麗宏;馬磊;朱正華;朱蕭玲;王強(qiáng);呂巖;陳紹洋;;Electroacupuncture pretreatment induces the tolerance against focal cerebral ischemia through activation of Notch pathway[A];中華醫(yī)學(xué)會(huì)第五次全國(guó)重癥醫(yī)學(xué)大會(huì)論文匯編[C];2011年

6 黃佳圓;王銳;陳龍邦;;Expression of Notch-1 and Its Clinical Significance in Different Histological Subtypes of Human Lung Adenocarcinoma[A];2013華東胸部腫瘤論壇暨第六屆浙江省胸部腫瘤論壇論文集[C];2013年

7 ;Aberrant expression profile of Notch signaling pathway involved in immune thrombocytopenic purpura patients[A];第12屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要[C];2009年

8 ;Notch induced protein degradation in lymphoid development[A];第六屆全國(guó)免疫學(xué)學(xué)術(shù)大會(huì)論文集[C];2008年

9 ;The functions of ptrl in Notch and Integrin pathways[A];2012全國(guó)發(fā)育生物學(xué)大會(huì)摘要集[C];2012年

10 Yaochun Wang;Guorui Dou;Lin Wang;Hua Han;;Notch signaling:licenses and limits cellular responses to extrinsic stimulations?[A];中國(guó)生物化學(xué)與分子生物學(xué)會(huì)第十屆會(huì)員代表大會(huì)暨全國(guó)學(xué)術(shù)會(huì)議摘要集[C];2010年

相關(guān)重要報(bào)紙文章 前1條

1 ;為什么心在左肝在右？[N];新華每日電訊;2004年

相關(guān)博士學(xué)位論文 前10條

1 王凱;Notch信號(hào)在小鼠創(chuàng)傷性腦損傷后神經(jīng)元死亡中的作用及機(jī)制研究[D];第四軍醫(yī)大學(xué);2015年

2 陳娟娟;Notch重組配體D1R在促進(jìn)造血重建中的作用與機(jī)理[D];第四軍醫(yī)大學(xué);2015年

3 梁燕;Notch3對(duì)低氧誘導(dǎo)的人肺動(dòng)脈平滑肌細(xì)胞增殖的作用機(jī)制探討[D];首都醫(yī)科大學(xué);2014年

4 孫建華;肺癌患者在乏氧條件下VEGF和Dll4/Notch通路分子的異常表達(dá)和相互關(guān)系[D];山東大學(xué);2015年

5 付偉;Notch信號(hào)在慢性粒細(xì)胞白血病細(xì)胞增殖和伊馬替尼耐藥的調(diào)控作用研究[D];第四軍醫(yī)大學(xué);2014年

6 柏振江;Notch配體DLL4在手足口病患兒中表達(dá)、臨床意義和功能分析[D];蘇州大學(xué);2016年

7 田z，

本文編號(hào)：2294620